BioCryst Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
BCRX
CUSIP
09058V103
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 284 174 M $1.31 B
2024 Q4 276 168 M $1.26 B
2024 Q3 275 173 M $1.32 B
2024 Q2 257 177 M $1.09 B
2024 Q1 262 186 M $948 M
2023 Q4 254 182 M $1.09 B
2023 Q3 250 176 M $1.24 B
2023 Q2 255 174 M $1.23 B
2023 Q1 261 171 M $1.42 B
2022 Q4 252 169 M $2.21 B
2022 Q3 257 149 M $1.88 B
2022 Q2 239 152 M $1.61 B
2022 Q1 260 128 M $2.10 B
2021 Q4 229 120 M $1.66 B
2021 Q3 221 103 M $1.48 B
2021 Q2 217 105 M $1.65 B
2021 Q1 211 105 M $1.06 B
2020 Q4 198 123 M $914 M
2020 Q3 171 128 M $438 M
2020 Q2 187 133 M $636 M
2020 Q1 148 123 M $245 M
2019 Q4 150 139 M $480 M
2019 Q3 125 98.8 M $283 M
2019 Q2 140 101 M $383 M
2019 Q1 147 102 M $826 M
2018 Q4 135 102 M $827 M
2018 Q3 130 101 M $774 M
2018 Q2 111 88.1 M $505 M
2018 Q1 111 90.0 M $429 M
2017 Q4 124 90.3 M $443 M
2017 Q3 135 83.7 M $439 M
2017 Q2 129 69.1 M $384 M
2017 Q1 135 68.1 M $572 M
2016 Q4 138 58.7 M $372 M
2016 Q3 120 56.6 M $249 M
2016 Q2 105 51.8 M $147 M
2016 Q1 115 55.5 M $157 M
2015 Q4 134 63.1 M $651 M
2015 Q3 138 65.1 M $742 M
2015 Q2 133 63.0 M $941 M
2015 Q1 106 65.1 M $588 M
2014 Q4 100 60.8 M $740 M
2014 Q3 111 56.7 M $555 M
2014 Q2 113 53.4 M $681 M
2014 Q1 93 43.5 M $461 M